0709 203000 - Nairobi 0709 983000 - Kilifi
  • Home
  • About Us
  • People
    • Management
    • Nairobi Programme Team
    • Clinical Research
    • Epidemiology & Demography
    • Bioscience
    • Health Systems & Research Ethics
    • Operations Team
  • The Programme
    • Programme Strategy
      • Discovery and Development
      • Surveillance and metrics
      • Intervention
      • Access and quality
      • Research Capacity
    • Research platforms
      • Ethics
      • Engagement
      • Surveillance
      • Clinical Research Unit
    • Scientific Departments
      • Clinical Research
      • Epidemiology and Demography
      • Bioscience
      • Health Systems and Research Ethics
    • Operations
      • Finance
      • Grants and Management and Procurement efficiency
      • People and Culture
      • Facilities and Transport
      • Health and Safety
  • Publications
  • Bioscience
  • Home
  • About Us
  • People
    • Management
    • Nairobi Programme Team
    • Clinical Research
    • Epidemiology & Demography
    • Bioscience
    • Health Systems & Research Ethics
    • Operations Team
  • The Programme
    • Programme Strategy
      • Discovery and Development
      • Surveillance and metrics
      • Intervention
      • Access and quality
      • Research Capacity
    • Research platforms
      • Ethics
      • Engagement
      • Surveillance
      • Clinical Research Unit
    • Scientific Departments
      • Clinical Research
      • Epidemiology and Demography
      • Bioscience
      • Health Systems and Research Ethics
    • Operations
      • Finance
      • Grants and Management and Procurement efficiency
      • People and Culture
      • Facilities and Transport
      • Health and Safety
  • Publications
  • Bioscience
  • Home
  • About Us
  • People
    • Management
    • Nairobi Programme Team
    • Clinical Research
    • Epidemiology & Demography
    • Bioscience
    • Health Systems & Research Ethics
    • Operations Team
  • The Programme
    • Programme Strategy
      • Discovery and Development
      • Surveillance and metrics
      • Intervention
      • Access and quality
      • Research Capacity
    • Research platforms
      • Ethics
      • Engagement
      • Surveillance
      • Clinical Research Unit
    • Scientific Departments
      • Clinical Research
      • Epidemiology and Demography
      • Bioscience
      • Health Systems and Research Ethics
    • Operations
      • Finance
      • Grants and Management and Procurement efficiency
      • People and Culture
      • Facilities and Transport
      • Health and Safety
  • Publications
  • Bioscience
  • Home
  • About Us
  • People
    • Management
    • Nairobi Programme Team
    • Clinical Research
    • Epidemiology & Demography
    • Bioscience
    • Health Systems & Research Ethics
    • Operations Team
  • The Programme
    • Programme Strategy
      • Discovery and Development
      • Surveillance and metrics
      • Intervention
      • Access and quality
      • Research Capacity
    • Research platforms
      • Ethics
      • Engagement
      • Surveillance
      • Clinical Research Unit
    • Scientific Departments
      • Clinical Research
      • Epidemiology and Demography
      • Bioscience
      • Health Systems and Research Ethics
    • Operations
      • Finance
      • Grants and Management and Procurement efficiency
      • People and Culture
      • Facilities and Transport
      • Health and Safety
  • Publications
  • Bioscience

Back Home

Anthony Scott/PLoS Med


5 results

The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries.Flasche S, Van Hoek AJ, Goldblatt D, Edmunds WJ, O'Brien KL, Miller E
PLoS Med, (2015). 12:e1001839

What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries?.
PLoS Med, (2008). 5:e86

What is the future for global case management guidelines for common childhood diseases?.
PLoS Med, (2008). 5:e241

Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya.Abwao J, Pamba A, Peenze I, Dewar J, Maghenda JK, Gatakaa H, Bauni E
PLoS Med, (2008). 5:e153

Defining childhood severe falciparum malaria for intervention studies.Berkley JA, Mwangi T, Ogada E, Mwangi I, Williams T, Lowe BS
PLoS Med, (2007). 4:e251

Source Titles
Clin Infect Dis(19)
PLoS One(10)
Vaccine(6)
PLoS Med(5)
Lancet(5)
J Clin Microbiol(5)
Bull World Health Organ(4)
Pediatr Infect Dis J(3)
Lancet Glob Health(3)
J Infect Dis(3)
Epidemiology(3)
Clin Diagn Lab Immunol(3)
BMC Public Health(3)
N Engl J Med(2)
J Am Heart Assoc(2)
Emerg Infect Dis(2)
BMC Genomics(2)
Sci Adv(1)
Proc Natl Acad Sci U S A(1)
Microorganisms(1)

KWTRP

Kilifi Headquater

We are Leading International Consulting Firm Specializing in Financial Investment.

  • +01 234 567 89
  • jwsthemes@gmail.com
  • www.zahar.com

OUR LOCATION

Global Company

  • New York: +01 123 456 789
  • Tokyo: +45 556 789 123
  • Sweden: +47 546 789 123

OUR IN TOUCH

Social Links

The best of the best is combined in ZAHAR. Lorem ipsum dolor sit amet.

Facebook-f Twitter Pinterest-p Instagram Rss